Transcriptome sequencing of murine ACP models and human tumor samples using laser capture microdissection has revealed overactivated MAPK/ERK pathways in tumor components, implying that MEK inhibitors could be developed as a potential treatment (11). The gene discussed is MAPK1; the disease is neoplasm.